Back to Search
ANNA BRAMLEY CATINO M.D.
M.D.
Cardiovascular Disease Physician
NPI: 1427282318IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
10250A(WY)
Education
UNIVERSITY OF VERMONT COLLEGE OF MEDICINE
Class of 2009
Research & Publications (14)
VEGF concentration from plasma-activated platelets rich correlates with microvascular density and grading in canine mast cell tumour spontaneous model.
PMID 18429933·J Cell Mol Med·2009
7-preclinical
Dose-dense primary chemotherapy, as part of multidisciplinary treatment, for inoperable stage III B breast cancer--long-term results of a phase II trial.
PMID 17998786·Oncology·2007
3-trial
The oxidative mannich reaction catalyzed by dirhodium caprolactamate.
PMID 16637627·J Am Chem Soc·2006
8-other
Efficient aziridination of olefins catalyzed by mixed-valent dirhodium(II,III) caprolactamate.
PMID 15957947·Org Lett·2005
8-other
Radiofrequency ablation of 40 lung neoplasms: preliminary results.
PMID 15269026·AJR Am J Roentgenol·2004
8-other
Dirhodium(II) caprolactamate: an exceptional catalyst for allylic oxidation.
PMID 15493912·J Am Chem Soc·2004
8-other
Serum vascular endothelial growth factor concentrations in hepatocellular cancer patients undergoing percutaneously radiofrequency thermal ablation.
PMID 15675467·J Chemother·2004
8-other
Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer.
PMID 12592360·Br J Cancer·2003
3-trial
Hypoxic stop-flow perfusion with mitomycin-C in the treatment of multifocal liver metastases. Usefulness of a vascular arterial stent to prevent iatrogenic lesions of the hepatic arterial wall.
PMID 16767932·J Exp Clin Cancer Res·2003
3-trial
Epithelial ovarian cancer: second and third line chemotherapy (review).
PMID 12063566·Int J Oncol·2002
6-review
Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study.
PMID 11239758·Eur J Cancer·2001
3-trial
High efficacy of paclitaxel and doxorubicin as first-line therapy in advanced breast cancer: a phase I-II study.
PMID 10949988·J Chemother·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 555 E BROADWAY AVE STE 229
JACKSON, WY 83001 - Phone
- (307) 739-7690
Quick Facts
- NPI
- 1427282318
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 17
- Publications
- 14
Are you this provider?
Claim Your Profile